title: Leflunomide-induced subacute cutaneous lupus erythematosus.
authors.forename: V
authors.initials: V
authors.lastname: Goëb
authors.forename: J M
authors.initials: JM
authors.lastname: Berthelot
authors.forename: P
authors.initials: P
authors.lastname: Joly
authors.forename: O
authors.initials: O
authors.lastname: Mejjad
authors.forename: J
authors.initials: J
authors.lastname: de Quatrebarbes
authors.forename: C
authors.initials: C
authors.lastname: Reynaud-Hautin
authors.forename: O
authors.initials: O
authors.lastname: Vittecoq
authors.forename: X
authors.initials: X
authors.lastname: Le Loët
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D008875:Middle Aged
chemical_list: D018501:Antirheumatic Agents; D007555:Isoxazoles; D000077339:Leflunomide